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Equine platelet /3 tropomyosin (247 residues), like rabbit skeletal muscle cy tropomyosin (284 residues) has 
a repeating pattern of amino acid residues characterisitic of a coiled-coil structure. When compared with 
the muscle protein, it is extended by 5 residues at the NHz-terminus and possesses two 21 residue deletions 
(positions 23-43 and 60-80 of the muscle sequence). The two proteins are highly conserved from residues 
81-260, but are significantly different at their COOH-termini (residues 261-284). These differences in 
platelet ropomyosin can be correlated with its diminshed head-to-tail polymerization, a weaker interaction 
with F-actin and a reduced affinity for muscle troponin and the Tl fragment of troponin-T. 
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1. INTRODUCTION 
Tropomyosins of skeletal and cardiac tissues are 
intimately involved, along with the troponin (Tn) 
complex, in the thin-filament-linked regulatory 
system for calcium control of actomyosin interac- 
tion (reviews [1,2]). Each tropomyosin (TM) 
molecule is rod-like in shape, 41 nm long, and 
composed of two highly m-helical subunits wrap- 
ped around each other to form a coiled-coil. 
Various periodic and aperiodic features of its 
amino acid sequence have been correlated with the 
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stabilization of its coiled-coil in a non-staggered 
parallel structure, with its head-to-tail aggregation 
into long molecular filaments and with its interac- 
tions with F-actin and Tn (review [3]). 
TM’s have also been identified in a number of 
non-muscle tissues, including platelets, brain, pan- 
creas, fibroblasts, sea urchin eggs and mammalian 
cultured cells [4-121. The platelet protein [4,10] 
has an a-helical content >90% and an amino acid 
composition similar to that of muscle TM. 
However, the subunit M, is 930000, with an axial 
repeat in its paracrystals of -34 nm, significantly 
shorter than that (39.5 nm) observed in 
paracrystals of muscle TM. Although there have 
been reports of higher M, forms of TM in non- 
muscle cells grown in culture [12,13], those 
detected in differentiated non-muscle tissues ap- 
pear to be predominantly of the low-M, variety and 
to have very similar peptide maps after digestion 
with chymotrypsin [7]. 
Equine platelet TM polymerizes less extensively 
in head-to-tail manner, binds more weakly to both 
platelet and muscle F-actin, interacts less strongly 
with Tn, Tn-T and the Tl fragment (residues 
1-158) of Tn-T and is less effective than muscle 
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TM in the calcium-regulated actomyosin subfrag- 
ment 1-Tm-Tn ATPase system [ 10,14- 181. 
However, the platelet protein is similar to muscle 
TM in its interaction with the T2 fragment 
(residues 159-259) of Tn-T and in the Ca2+ sen- 
sitivity of this interaction in the presence of Tn-C 
[18]. To provide further information on the rela- 
tionships between the structure of platelet TM and 
its functional properties described above, we 
undertook the elucidation of its amino acid se- 
quence, the results of which are described here. 
2. EXPERIMENTAL 
TM, isolated as in [lo], migrated as LY and fl 
components (molar ratio 1:2) on 
SDS-polyacrylamide electrophoretic gels in the 
presence of 6 M urea. Attempts to separate these 
on a preparative scale were unsuccessful and the 
amino acid sequence analyses were performed on 
the mixture. Where more than one sequence was 
observed corresponding to a particular region of 
the platelet TM structure, the peptide isolated in 
greater yield was assumed to have been derived 
from the fl component. For sequence analysis, 
fragments were generated by cyanogen bromide 
cleavage and tryptic digestion of the citraconylated 
proteins. Following their purification and 
decitraconylation, the larger fragments were fur- 
ther digested with trypsin, thermolysin or 
Staphylococcus aureus protease V8. Manual and 
automatic sequencing methods have been describ- 
ed [19-221. Full details of the sequence analysis 
will be reported elsewhere. Some aspects of this 
work have been reported in [14,15]. 
3. RESULTS AND DISCUSSION 
The sequence of platelet TM presented in fig.1 
represents the results of an analysis of the 
fragments and peptides generated from a mixture 
of LY and fl components in a ratio of about 1:2 in 
the isolated protein. In spite of this, surprisingly 
little heterogeneity was detected in the isolated 
peptides, indicating that the (Y and p components 
of the platelet protein are highly similar. 
Heterogeneity was observed at only two positions 
(residues 143 and 146) where peptides were isolated 
in lower yield in which Ile-106 and Met-109 were 
replaced by Leu and Ile. It must be emphasized, 
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Fig.1. Amino acid sequence of the ,&component of 
equine platelet TM. Sequence is arranged such that a-g 
positions of the repeating pseudo-heptapeptide, typical 
of a coiled-coil structure, are vertically aligned. The non- 
polar core positions a and d are boxed and circled 
respectively. Heterogeneity was observed at positions 
143 and 146, where peptides were recovered in lower 
yields in which Ile and Met were replaced by Leu and Ile, 
respectively. 
however, that since a number of fragments and 
peptides isolated in lower yields were not fully 
characterized in this study, the numbers of 
substitutions between the (Y and B components of 
the platelet protein may be larger than the two in- 
dicated above. 
One of the striking features of the muscle TM se- 
quence [20] is the repeating pattern of non-polar 
and polar residues responsible for the stabilization 
of its coiled-coil structure. As is evident from an 
inspection of the sequence of the platelet protein 
(fig.lj, this pattern is retained and is continuous 
from the NHz-terminus to the COOH-terminus. 
This is consistent with the known high a-helical 
content and other properties of the protein as 
described in [4,10,11]. The a and d positions of the 
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repeating pseudo-heptapeptide are largely oc- 3 similar residues in a total of 16. However, the 
cupied by non-polar residues and only occasionally placement of these regions in any other alignment 
by polar or charged residues. with the first 80 residues of muscle TM leads to a 
For a comparison of platelet TM with the muscle significantly decreased score level for identities and 
protein, the two sequences have been aligned to similarities. The alignment of the remaining se- 
maximize homology (fig.2). The platelet protein is quences is unambiguous, since from residues 
seen to be extended at the NH?-terminal end by 5 81-260 the sequences are highly conserved, and 
residues and to have two 21 residue deletions in the the polypeptide chain lengths to the COOH- 
first 80 residues of the muscle protein. Similarity is terminal ends (residue 284) are identical. Of a total 
maximized when residues 6-27 and 28-43 of of 180 residues from 81-260, there are only 25 
platelet TM are aligned with residues l-22 and substitutions, and in nearly every case these are 
44-59 of the muscle protein, respectively. The highly conservative in nature. From residues 
homology in the first of these alignments (residues 261-284, although there are no deletions or inser- 
6-27 with l-22) is very strong, with 9 identical and tions, the platelet sequence differs significantly 
6 similar residues out of a total of 22. The second from the muscle TM structure. This COOH- 
of these alignments is weaker, with 5 identities and terminal sequence, as reported here, differs from 
1 5 10 
AC-A-G-L-N-S-L-E-A-V-K-R-K-I-Q-A L 
AC-U -D-A- 
I# 
I-K-K-K-M-Q-II L 
26 30 35 
__________ ______- _ 
E-A-D-K-K-A-A-E-D-R-S- 
116 120 125 
146 150 155 160 165 170 
"-Q-L-K-E-A-K-A-I-A-E-E-A-D-R-K-Y-K-E-V-A-R-K-L-V-I-L-E 
I-Q -L-K-K- A-K-N-I-A-K-D-A-D-R-K-Y-E-E-V-A-R-K-L-V-I-I-E 
176 180 185 190 195 
L-E-R- 
L-K- 
236 240 245 250 255 260 265 
275 280 264 
Fig.2. Alignment of equine platelet fl- and rabbit skeletal muscle (u-TM sequences to maximize homology. The one-letter 
code for amino acids is used. Regions of identity and similarity are boxed. In this figure, the numbering scheme isthat 
for the muscle protein. Dashes (-) in the platelet sequence are deletions. pTM and mTM are platelet and muscle TMs, 
respectively. Chemically similar residues are defined here as: RzK; EsD; TzS; GzA; L=V=I=M. 
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that in [14]. The latter was a tentative result based 
only on the results of carboxypeptidase analyses of 
the intact protein. However, the important conclu- 
sion that this region of the platelet sequence differs 
from muscle TM is corroborated by the present 
more complete analyses. 
The two 21-residue deletions in platelet TM 
reduce its length by about l/7 when compared with 
muscle TM. Thus platelet TM can span only 6 ac- 
tin monomers on each of the two F-actin strands in 
agreement with recent qualitative binding studies 
of the protein to F-actin [15]. In addition to the 
two deletions there are significant differences in 
the platelet TM amino acid sequence when com- 
pared with residues l-80 of the muscle TM struc- 
ture. This suggests that the actin interaction pro- 
perties of this region of the molecule may differ 
significantly from those of its muscle counterpart. 
Like muscle TM, the interaction of platelet TM 
with both muscle and platelet F-actin is dependent 
on the medium [Mti’] [16]. Whereas the binding 
of muscle TM reaches a maximum at l-2 mM 
Mg*+, that of the platelet protein only reaches 
saturation when MgCl2 is increased to 8-10 mM 
and is incomplete at lower, more physiological 
levels. This weaker interaction can be attributed in 
part to the shorter length of the molecule with its 
reduced number of actin binding sites, as well as to 
changes in the binding sites of the NHz-terminal 
domain indicated above. A further important fac- 
tor affecting the binding of muscle and platelet 
TMs to F-actin is the extent to which the two pro- 
teins polymerize in a head-to-tail manner. It has 
been shown 1231 that the binding of 2 and 3 con- 
tiguous TM molecules to F-actin, linked through 
contacts at their ends, is increased dramatically 
over that for the binding of an isolated TM 
molecule. We have shown [ 141 that platelet TM ag- 
gregates in a head-to-tail manner less extensively 
than muscle TM and this is correlated here with 
significantly different amino acid sequences at 
both its NH*-terminal and COOH-terminal ends. 
Thus, the strength and cooperativity of platelet 
TM binding to F-actin is expected to be less than 
that with muscle TM and is explicable in terms of 
these structural differences. 
A further correlation of the similarities and dif- 
ferences exhibited by the platelet and muscle struc- 
tures can be made with respect o their interactions 
with the members of the Tn complex. Recent 
272 
observations have demonstrated that at least two 
regions on each of both Tn-T and muscle TM are 
involved in their mutual interaction [ 18,24-261. 
Thus, the Tl (residues 1-158) and CBl (residues 
1-151) fragments of Tn-T interact with a segment 
of TM close to or at its COOH-terminal end. This 
interaction is insensitive to Ca*+ in the presence of 
troponin-C [18]. On the other hand, the T2 region 
(residues 159-259) of Tn-T interacts with TM in 
the region of its cysteine-190 residue or -l/3 of the 
molecular distance from its COOH-terminal end 
[27]. This interaction is sensitive to [Ca*‘] in the 
presence of Tn-I and -C, with which T2 also in- 
teracts [18,27,28]. 
In the case of platelet TM, we had shown that 
the interactions with the troponin complex, with 
Tn-T and with its Tl and CBl fragments are 
significantly weaker than with the muscle protein 
[ 15,181. This is now explicable in terms of the 
structural differences which exist between the 
platelet and muscle proteins at their COOH- 
terminal ends (residues 260-284; see fig.2). Of par- 
ticular significance in this connection may be the 
replacement of tyrosine-261 and -267 by alanine 
and asparagine, respectively. The extent of iodina- 
tion by lactoperoxidase of these tyrosines, but not 
other tyrosines, in the muscle protein, is ap- 
preciably reduced in the presence of Tn or the CBl 
fragment of Tn-T, suggesting that they are involv- 
ed in the interaction at this site [24]. Their absence 
in the platelet structure is therefore consistent with 
a weaker interaction of the platelet protein with the 
CBl/Tl region of Tn-T. 
On the other hand, the T2 region (residues 
159-259) of Tn-T has been shown to interact 
equally well with both platelet and muscle TMs 
[ 181. This is fully consistent with the high degree of 
homology observed in their structures over an ex- 
tensive region from residues 81-260 and including 
those portions of their structures in the 
neighbourhood of cysteine-190 (see fig.2). 
Significantly, this interaction between T2 and 
platelet TM is also sensitive to [Ca”] in the 
presence of Tn-C [18,27]. 
Recently we have demonstrated that Tn-I in- 
teracts with muscle TM [28] and that Tn-I will in- 
duce the binding of both platelet and muscle TM 
to F-actin under conditions in which the TMs by 
themselves do not bind to F-actin [16]. This sug- 
gests that the binding sites on both TMs for Tn-I 
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are highly similar, a deduction consistent with the 
demonstration that the location of Tn-I, -C and 
the T2 fragment of Tn-T in the muscle thin- 
filament assembly are coincident 1251 and 
therefore in the region of cysteine-190 of muscle 
TM. 
These observations have certain implications for 
the structural and molecular properties of putative 
Tn-like components in non-muscle cells. They 
would suggest hat, if such proteins do in fact ex- 
ist, they can be expected to have substantially dif- 
ferent molecular and interaction properties than 
the more familiar muscle Tn components. This 
would be particularly true for any component(s) 
which might have a Tn-T-like function in such 
tissues, since the structural requirements for the 
binding of the Tl portion of muscle Tn-T to 
platelet TM are evidently lacking. In addition, the 
significant alterations in structure in the 
NHz-terminal region of the platelet TM suggest 
that this domain may interact with as yet uniden- 
tified protein component(s) in non-muscle tissues. 
Clearly, the identification and characterization of 
TM-binding proteins in non-muscle tissues would 
be a useful experimental approach to such ques- 
tions, an avenue of investigation we are presently 
pursuing. 
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